4.8 Correction

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (vol 50, pg 928, 2018)

Journal

NATURE GENETICS
Volume 51, Issue 2, Pages 363-363

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41588-018-0330-6

Keywords

-

Funding

  1. Cancer Research UK [10119, 10124, 14136] Funding Source: Medline
  2. Medical Research Council [MR/N003284/1, G1000143, G0401527] Funding Source: Medline
  3. NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200325] Funding Source: NIH RePORTER
  4. MRC [MR/N003284/1] Funding Source: UKRI

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Rheumatology

Long-Term Mortality of Patients With Osteoarthritis After Joint Replacement: Prognostic Value of Preoperative and Postoperative Pain and Function

Matthias Klimek, Gisela Buchele, Martin Rehm, Jan Beyersmann, Klaus-Peter Gunther, Hermann Brenner, Til Sturmer, Rolf E. Brenner, Dietrich Rothenbacher

Summary: This study aimed to investigate the relationship between OA-specific assessment values and long-term mortality in patients with advanced OA undergoing arthroplasty. The Ulm Osteoarthritis Study found that arthroplasty reduced pain and improved function, but there was no association between joint-specific WOMAC assessments and long-term mortality. However, generic function assessments were associated with increased risk of mortality.

ARTHRITIS CARE & RESEARCH (2023)

Article Urology & Nephrology

Clinical performance of magnetic resonance imaging and biomarkers for prostate cancer diagnosis in men at high genetic risk

Olivier Cussenot, Raphaele Renard-Penna, Sarah Montagne, Valerie Ondet, Antoine Pilon, Jerome Guechot, Eva Comperat, Freddie Hamdy, Alastair Lamb, Geraldine Cancel-Tassin

Summary: This study evaluates different scenarios for the management of early diagnosis of cancer (PCa) in men at high genetic risk using blood and urinary molecular biomarkers in combination with clinical information alongside multiparametric magnetic resonance imaging (mpMRI). The results suggest that screening based on mpMRI is more effective for detecting clinically significant PCa lesions compared to blood markers, and it is recommended to consider a baseline mpMRI for men at high genetic risk starting from the age of 40.

BJU INTERNATIONAL (2023)

Article Clinical Neurology

Migraine, inflammatory bowel disease and celiac disease: A Mendelian randomization study

Nike Zoe Welander, Gull Rukh, Mathias Rask-Andersen, Aster V. E. Harder, Arn M. J. M. van den Maagdenberg, Helgi Birgir Schioth, Jessica Mwinyi

Summary: This study found no evidence of a shared genetic basis or of a causal association between migraine and either IBD or celiac disease. However, there were indications of causal associations between celiac disease and migraine subtypes. Further research is needed to investigate these associations.

HEADACHE (2023)

Review Endocrinology & Metabolism

Can remnant cholesterol (triglyceride-rich lipoproteins) reclassify estimated risk of atherosclerotic cardiovascular disease?

Takahito Doi, Borge G. Nordestgaard, Anne Langsted

Summary: Recent studies have shown that including remnant cholesterol in risk assessment can significantly improve the accuracy of reclassifying individuals at risk of developing myocardial infarction and ischemic heart disease, both in primary and secondary prevention settings.

CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2023)

Article Genetics & Heredity

Severe COVID-19 May Impact Hepatic Fibrosis/Hepatic Stellate Cells Activation as Indicated by a Pathway and Population Genetic Study

Leire Moya, Samaneh Farashi, Prashanth Suravajhala, Panchadsaram Janaththani, Jyotsna Batra

Summary: COVID-19 has caused significant impacts globally, infecting over 112 million people and causing more than 2.5 million deaths. In Europe, Spain and Italy had a high number of COVID-19 related deaths, while many infected individuals did not develop severe illness. Researchers speculated that unique genomic characteristics in these populations could contribute to a poorer prognosis.

GENES (2023)

Article Multidisciplinary Sciences

GWAS Explorer: an open-source tool to explore, visualize, and access GWAS summary statistics in the PLCO Atlas

Mitchell J. Machiela, Wen-Yi Huang, Wendy Wong, Sonja I. Berndt, Joshua Sampson, Jonas De Almeida, Mustapha Abubakar, Jada Hislop, Kai-Ling Chen, Casey Dagnall, Norma Diaz-Mayoral, Mary Ferrell, Michael Furr, Alex Gonzalez, Belynda Hicks, Aubrey K. Hubbard, Amy Hutchinson, Kevin Jiang, Kristine Jones, Jia Liu, Erikka Loftfield, Jennifer Loukissas, Jerome Mabie, Shannon Merkle, Eric Miller, Lori M. Minasian, Ellen Nordgren, Brian Park, Paul Pinsky, Thomas Riley, Lorena Sandoval, Neeraj Saxena, Aurelie Vogt, Jiahui Wang, Craig Williams, Patrick Wright, Meredith Yeager, Bin Zhu, Claire Zhu, Stephen J. Chanock, Montserrat Garcia-Closas, Neal D. Freedman

Summary: The PLCO Cancer Screening Trial is a prospective cohort study that developed the PLCO Atlas Project, a large resource for GWAS. Genotyping was performed on participants with available DNA, and GWAS were conducted using a custom pipeline. The PLCO Atlas GWAS Explorer website, with APIs and SDKs, allows for exploration, visualization, and open data access. It currently hosts association data for 90 traits and >78 million genomic markers, focusing on cancer-related phenotypes. The PLCO Atlas is a FAIR resource for cancer research and genetic epidemiology.

SCIENTIFIC DATA (2023)

Review Cell Biology

Efficacy of vitamin D3 supplementation on cancer mortality: Systematic review and individual patient data meta-analysis of randomised controlled trials

Sabine Kuznia, Anna Zhu, Taisuke Akutsu, Julie E. Buring, Carlos A. Camargo Jr, Nancy R. Cook, Li-Ju Chen, Ting-Yuan David Cheng, Sari Hantunen, I. -Min Lee, JoAnn E. Manson, Rachel E. Neale, Robert Scragg, Aladdin H. Shadyab, Sha Sha, John Sluyter, Tomi-Pekka Tuomainen, Mitsuyoshi Urashima, Jyrki K. Virtanen, Ari Voutilainen, Jean Wactawski-Wende, Mary Waterhouse, Hermann Brenner, Ben Schoettker

Summary: A systematic review and meta-analysis of randomized, placebo-controlled trials (RCTs) and individual patient data (IPD) was conducted to evaluate the effect of vitamin D3 supplementation on cancer mortality in the general population and on prognosis in cancer patients. The main meta-analysis of the 14 RCTs showed a non-significant reduction in cancer mortality by 6%. Subgroup analyses revealed a significant reduction in cancer mortality in trials with daily dosing, while no reduction was seen in trials using a bolus regimen. The IPD meta-analysis confirmed the findings of all trials.

AGEING RESEARCH REVIEWS (2023)

Article Genetics & Heredity

Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry

Burcu F. Darst, Jiayi Shen, Ravi K. Madduri, Alexis A. Rodriguez, Yukai Xiao, Xin Sheng, Edward J. Saunders, Tokhir Dadaev, Mark N. Brook, Thomas J. Hoffmann, Kenneth Muir, Peggy Wan, Loic Le Marchand, Lynne Wilkens, Ying Wang, Johanna Schleutker, Robert J. MacInnis, Cezary Cybulski, David E. Neal, Borge G. Nordestgaard, Sune F. Nielsen, Jyotsna Batra, Judith A. Clements, Henrik Gronberg, Nora Pashayan, Ruth C. Travis, Jong Y. Park, Demetrius Albanes, Stephanie Weinstein, Lorelei A. Mucci, David J. Hunter, Kathryn L. Penney, Catherine M. Tangen, Robert J. Hamilton, Marie-Elise Parent, Janet L. Stanford, Stella Koutros, Alicja Wolk, Karina D. Sorensen, William J. Blot, Edward D. Yeboah, James E. Mensah, Yong-Jie Lu, Daniel J. Schaid, Stephen N. Thibodeau, Catharine M. West, Christiane Maier, Adam S. Kibel, Geraldine Cancel-Tassin, Florence Menegaux, Esther M. John, Eli Marie Grindedal, Kay-Tee Khaw, Sue A. Ingles, Ana Vega, Barry S. Rosenstein, Manuel R. Teixeira, Manoli Kogevinas, Lisa Cannon-Albright, Chad Huff, Luc Multigner, Radka Kaneva, Robin J. Leach, Hermann Brenner, Ann W. Hsing, Rick A. Kittles, Adam B. Murphy, Christopher J. Logothetis, Susan L. Neuhausen, William B. Isaacs, Barbara Nemesure, Anselm J. Hennis, John Carpten, Hardev Pandha, Kim De Ruyck, Jianfeng Xu, Azad Razack, Soo-Hwang Teo, Lisa F. Newcomb, Jay H. Fowke, Christine Neslund-Dudas, Benjamin A. Rybicki, Marija Gamulin, Nawaid Usmani, Frank Claessens, Manuela Gago-Dominguez, Jose Esteban Castelao, Paul A. Townsend, Dana C. Crawford, Gyorgy Petrovics, Graham Casey, Monique J. Roobol, Jennifer F. Hu, Sonja I. Berndt, Stephen K. van den Eeden, Douglas F. Easton, Stephen J. Chanock, Michael B. Cook, Fredrik Wiklund, John S. Witte, Rosalind A. Eeles, Zsofia Kote-Jarai, Stephen Watya, John M. Gaziano, Amy C. Justice, David V. Conti, Christopher A. Haiman

Summary: In this study, the predictive ability of several genome-wide polygenic risk score (GW-PRS) approaches was compared to a recently developed PRS of established prostate cancer-risk variants. The findings suggest that the PRS269 developed from multi-ancestry GWASs and fine-mapping has better predictive ability for prostate cancer risk compared to current GW-PRS approaches.

AMERICAN JOURNAL OF HUMAN GENETICS (2023)

Article Cardiac & Cardiovascular Systems

Genetic testing increases the likelihood of a diagnosis of familial hypercholesterolaemia among people referred to lipid clinics: Danish national study

Berit Storgaard Hedegaard, Christian Sorensen Bork, Helle Lynge Kanstrup, Kristian Korsgaard Thomsen, Merete Heitmann, Lia Evi Bang, Finn Lund Henriksen, Lars Juel Andersen, Thomas Gohr, Mette Rauhe Mouridsen, Anne Merete Boas Soja, Frank-Peter Elpert, Tomas Joen Jakobsen, Anette Sjol, Albert Marni Joensen, Borge Gronne Nordestgaard, Ib Christian Klausen, Erik Berg Schmidt

Summary: This study investigated the percentage of familial hypercholesterolaemia (FH) among patients referred to Danish lipid clinics and evaluated the impact of genetic testing on FH diagnosis. The results showed that genetic testing increased the diagnosis rate of FH from 22% to 37%. Therefore, a more widespread use of genetic testing is recommended for evaluating a possible FH diagnosis and potential cascade screening.

ATHEROSCLEROSIS (2023)

Article Urology & Nephrology

Standardized prostate cancer incidence and mortality rates following initial non-malignant biopsy result

Hein V. Stroomberg, Marc C. M. Andersen, John Thomas Helgstrand, Signe Benzon Larsen, Andrew J. Vickers, Emeritus Klaus Brasso, Andreas Roder

Summary: A study in Denmark involving 37,231 men who had an initial non-malignant transrectal ultrasonography (TRUS) biopsy showed that these men had a higher incidence of subsequent prostate cancer but a lower risk of prostate cancer death compared to the general population. It suggests that the oncological risk of cancers missed in the initial TRUS biopsy is low, and attempts to increase biopsy sensitivity are unwarranted. Current follow-up after a non-malignant biopsy may be overaggressive, especially for men over the age of 60.

BJU INTERNATIONAL (2023)

Article Public, Environmental & Occupational Health

The association between body fatness and mortality among breast cancer survivors: results from a prospective cohort study

Catalina Bonet, Marta Crous-Bou, Konstantinos K. Tsilidis, Marc J. Gunter., Rudolf Kaaks., Matthias. B. Schulze, Renee T. Fortner, Christian S. Antoniussen, Christina C. Dahm, Lene Mellemkjaer, Anne Tjonneland, Pilar Amiano, Eva Ardanaz, Sandra M. Colorado-Yohar, Miguel Rodriguez-Barranco, Sandar Tin Tin, Claudia Agnoli, Giovanna Masala, Salvatore Panico, Carlotta Sacerdote, Anne M. May, Kristin Benjaminsen Borch, Charlotta Rylander, Guri Skeie, Sofia Christakoudi, Dagfinn Aune, Elisabete Weiderpass, Laure Dossus, Elio Riboli, Antonio Agudo

Summary: The study aimed to assess the association between body fatness and weight changes and overall mortality and BC-specific mortality among BC survivors. The results showed that excess body fatness is linked to poorer survival in women with BC, and substantial weight changes postdiagnosis may contribute to poorer survival.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2023)

Article Genetics & Heredity

Polymorphic variants involved in methylation regulation: a strategy to discover risk loci for pancreatic ductal adenocarcinoma

Chiara Corradi, Giulia Lencioni, Manuel Gentiluomo, Alessio Felici, Anna Latiano, Gediminas Kiudelis, Casper H. J. van Eijck, Katalin Marta, Rita T. Lawlor, Francesca Tavano, Ugo Boggi, Frederike Dijk, Giulia Martina Cavestro, Roel C. H. Vermeulen, Thilo Hackert, Maria Chiara Petrone, Faik Guentac Uzunoglu, Livia Archibugi, Jakob R. Izbicki, Luca Morelli, Alessandro Zerbi, Stefano Landi, Hannah Stocker, Renata Talar-Wojnarowska, Gregorio Di Franco, Peter Hegyi, Cosimo Sperti, Silvia Carrara, Gabriele Capurso, Maria Gazouli, Hermann Brenner, Stefania Bunduc, Olivier Busch, Francesco Perri, Martin Oliverius, Peter Jeno Hegyi, Mara Goetz, Pasquale Scognamiglio, Andrea Mambrini, Paolo Giorgio Arcidiacono, Edita Kreivenaite, Juozas Kupcinskas, Tamas Hussein, Stefano Ermini, Anna Caterina Milanetto, Pavel Vodicka, Vytautas Kiudelis, Viktor Hlavac, Pavel Soucek, George E. Theodoropoulos, Daniela Basso, John P. Neoptolemos, Mateus Nobrega Aoki, Raffaele Pezzilli, Claudio Pasquali, Roger Chammas, Sabrina Gloria Giulia Testoni, Beatrice Mohelnikova-Duchonova, Maurizio Lucchesi, Cosmeri Rizzato, Federico Canzian, Daniele Campa

Summary: This study identified a novel risk locus for PDAC which modulates cancer risk by controlling gene expression through DNA methylation.

JOURNAL OF MEDICAL GENETICS (2023)

Article Oncology

PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants

Taru Muranen, Anna Morra, Sofia R. Khan, Daniel K. Barnes, Manjeet Bolla, Joe Dennis, Renske Keeman, Goska T. Leslie, Michael Parsons, Qin U. Wang, Thomas Ahearn, Kristiina L. Aittomaeki, Irene K. Andrulis, Banu Arun, Sabine Behrens, Katarzyna E. Bialkowska, Stig J. Bojesen, Nicola Camp, Jenny Chang-Claude, Kamila Czene, Peter M. Devilee, Susan M. Domchek, Alison Dunning, Christoph Engel, D. Gareth Evans, Manuela Gago-Dominguez, Montserrat Garcia-Closas, Anne-Marie Gerdes, Gord Glendon, Pascal Guenel, Eric Hahnen, Ute Hamann, Helen J. Hanson, Maartje Hooning, Reiner Hoppe, Louise Izatt, Anna A. Jakubowska, Paul N. James, Vessela Kristensen, Fiona J. Lalloo, Geoffrey Lindeman, Arto Mannermaa, Sara L. Margolin, Susan G. Neuhausen, William Newman, Paolo Peterlongo, Kelly-Anne Phillips, Miquel Angel Pujana, Johanna Rantala, Karina Ronlund, Emmanouil K. Saloustros, Rita Schmutzler, Andreas F. Schneeweiss, Christian Singer, Maija Suvanto, Yen Yen R. Tan, Manuel Teixeira, Mads Thomassen, Marc Tischkowitz, Vishakha Tripathi, Barbara Wappenschmidt, Emily F. Zhao, Douglas C. Easton, Antonis Antoniou, Georgia Chenevix-Trench, Paul D. P. K. Pharoah, Marjanka Schmidt, Carl Blomqvist, Heli Nevanlinna

Summary: This study assessed the PREDICT v 2.2 for prognosis of breast cancer patients with pathogenic germline BRCA1 and BRCA2 variants. The results showed that PREDICT had modest discrimination for BRCA1 carrier patients with ER-negative breast cancer, but clearly distinguished the high-mortality group from lower risk categories. However, for ER-positive breast cancer, the discrimination was slightly lower in BRCA2 variant carriers, and the inclusion of tumor grade distorted the prognostic estimates.

NPJ BREAST CANCER (2023)

Article Respiratory System

Interactions of platelets with obesity in relation to lung cancer risk in the UK Biobank cohort

Sofia Christakoudi, Konstantinos K. Tsilidis, Evangelos Evangelou, Elio Riboli

Summary: In men, platelet count is positively associated with lung cancer risk, while platelet size is inversely associated, with these associations being affected by obesity. In women, only platelet count is positively associated with lung cancer risk, with little evidence of interaction with obesity.

RESPIRATORY RESEARCH (2023)

No Data Available